Rx (Prescription Medicine)
USD $ 7.00
Celdaz 500mg 注射剂是一种强效抗生素药物，用于治疗多种细菌感染。其活性成分为头孢第三代化合物Ceftriaxone，属于头孢类抗生素。Ceftriaxone通过抑制细菌细胞壁合成，阻断细菌生存所必需的关键过程。通过破坏这一过程，Celdaz能够有效杀死感受药物的细菌，使机体免疫系统清除感染。
该注射剂适用于多种严重细菌感染的治疗，包括下呼吸道感染、泌尿生殖系统感染、皮肤及软组织感染、骨与关节感染、腹腔内感染以及脑膜炎。亦可用于手术后预防感染。
Celdaz 500mg 注射剂的用药剂量及疗程取决于感染的严重程度及患者的反应。通常由医护人员通过肌肉注射或静脉注射给药。
常见不良反应可能包括注射部位疼痛或肿胀、腹泻、恶心和皮疹。严重不良反应虽罕见但可能发生，需立即就医。对头孢类或青霉素已知过敏史的患者不应使用本药。
Celdaz 500mg 注射剂应储存在室温，避光防潮。请务必遵循医护人员关于用药的指示。
| Molecule | |
|---|---|
| Strength | |
| Pack Quantity | |
| Medicine Form | |
| Medicine Type | |
| Rx Status | |
| Country Of Origin | |
| Packaging Type | |
| Brand Name |
未库存此 exact 强度的其他品牌，因此这些是其他强度的 Dacarbazine. 未经开方医生建议，请勿更改剂量。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
